9 month share price target is +$2.00 share, page-78

$2 is wishful thinking. Growth would need to accelerate on a % measurement for that to occur. I noticed that growth as a percent was down last quarter, WITH the BHA revenue. So, I'm not certain $2 is within our 7 month time frame. In fact I'm certain it isn't.

As a large holder, happy to be proven wrong. I'd be happy with any price between $1.20 - $1.50 and I think that's much more likely, u less US and UK ramp up to something like 20% of revenue - doubt they will in such a short time frame.